{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T01:28:57Z","timestamp":1787362137065,"version":"build-2736575974"},"reference-count":23,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["annallergy.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Allergy, Asthma & Immunology"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.anai.2016.07.018","type":"journal-article","created":{"date-parts":[[2016,9,9]],"date-time":"2016-09-09T04:22:39Z","timestamp":1473394959000},"page":"310-317","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Efficacy of the novel nasal steroid S0597 tested in an environmental exposure unit"],"prefix":"10.1016","volume":"117","author":[{"given":"Anne K.","family":"Ellis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa M.","family":"Steacy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhijeet","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shravanti","family":"Bhowmik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atul","family":"Raut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.anai.2016.07.018_bib1","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/S0140-6736(06)69283-0","article-title":"Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys","volume":"368","author":"Asher","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.anai.2016.07.018_bib2","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1183\/09031936.04.00013904","article-title":"Prevalence and rate of diagnosis of allergic rhinitis in Europe","volume":"24","author":"Bauchau","year":"2004","journal-title":"Eur Respir J"},{"issue":"suppl 86","key":"10.1016\/j.anai.2016.07.018_bib3","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1398-9995.2007.01620.x","article-title":"Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen)","volume":"63","author":"Bousquet","year":"2008","journal-title":"Allergy"},{"key":"10.1016\/j.anai.2016.07.018_bib4","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/j.1365-2222.2011.03891.x","article-title":"Prevalence and diversity of allergic rhinitis in regions of the world beyond Europe and North America","volume":"42","author":"Katelaris","year":"2012","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.anai.2016.07.018_bib5","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.jaci.2010.06.047","article-title":"Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 revision","volume":"126","author":"Brozek","year":"2010","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2016.07.018_bib6","doi-asserted-by":"crossref","first-page":"S150","DOI":"10.1016\/S0091-6749(99)70311-8","article-title":"A\u00a0review of the preclinical and clinical data of newer intranasal steroids used in the treatment of allergic rhinitis","volume":"104","author":"Lumry","year":"1999","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2016.07.018_bib7","doi-asserted-by":"crossref","first-page":"413","DOI":"10.2500\/aap.2011.32.3473","article-title":"Safety update regarding intranasal corticosteroids for the treatment of allergic rhinitis","volume":"32","author":"Blaiss","year":"2011","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.anai.2016.07.018_bib8","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1002\/cpdd.136","article-title":"Safety, tolerability, pharmacokinetics, and pharmacodynamics of compound SFDAC by intranasal administration of multiple escalating dose in healthy male subjects","volume":"3","author":"Thennati","year":"2014","journal-title":"Clin Pharmacol Drug Dev"},{"key":"10.1016\/j.anai.2016.07.018_bib9","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.anai.2015.07.016","article-title":"Efficacy and safety of a novel nasal steroid, S0597, in patients with seasonal allergic rhinitis","volume":"115","author":"Badorrek","year":"2015","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.anai.2016.07.018_bib10","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/S0091-6749(96)70257-9","article-title":"A\u00a0randomized, double-blind, placebo-controlled, controlled antigen delivery study of the onset of action of aerosolized triamcinolone acetonide nasal spray in subjects with ragweed-induced allergic rhinitis","volume":"97","author":"Day","year":"1996","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2016.07.018_bib11","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1067\/mai.2000.104550","article-title":"Onset of action of intranasal budesonide (Rhinocort aqua) in seasonal allergic rhinitis studied in a controlled exposure model","volume":"105","author":"Day","year":"2000","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2016.07.018_bib12","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.anai.2013.07.019","article-title":"Environmental exposure unit: a sensitive, specific, and reproducible methodology for allergen challenge","volume":"111","author":"Ellis","year":"2013","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.anai.2016.07.018_bib13","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1517\/14656560902758368","article-title":"Bepotastine besilate OD tablets suppress nasal symptoms caused by Japanese cedar pollen exposure in an artificial exposure chamber (OHIO Chamber)","volume":"10","author":"Hashiguchi","year":"2009","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.anai.2016.07.018_bib14","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/j.1398-9995.2005.00703.x","article-title":"Effect of loteprednol etabonate nasal spray suspension on seasonal allergic rhinitis assessed by allergen challenge in an environmental exposure unit","volume":"60","author":"Krug","year":"2005","journal-title":"Allergy"},{"key":"10.1016\/j.anai.2016.07.018_bib15","doi-asserted-by":"crossref","first-page":"592","DOI":"10.2500\/aap2007.28.3033","article-title":"Onset and duration of action of nasal sprays in seasonal allergic rhinitis patients: olopatadine hydrochloride versus mometasone furoate monohydrate","volume":"28","author":"Patel","year":"2007","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.anai.2016.07.018_bib16","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1185\/03007990802155792","article-title":"Fluticasone furoate versus placebo in symptoms of grass-pollen allergic rhinitis induced by exposure in the Vienna Challenge Chamber","volume":"24","author":"Zieglmayer","year":"2008","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.anai.2016.07.018_bib17","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.anai.2010.01.012","article-title":"Factors that affect the allergic rhinitis response to ragweed allergen exposure","volume":"104","author":"Ellis","year":"2010","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.anai.2016.07.018_bib18","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s13223-015-0071-3","article-title":"Clinical validation of controlled grass pollen challenge in the Environmental Exposure Unit (EEU)","volume":"11","author":"Ellis","year":"2015","journal-title":"Allergy Asthma Clin Immunol"},{"key":"10.1016\/j.anai.2016.07.018_bib19","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1710-1492-10-33","article-title":"Add-on histamine receptor-3 antagonist for allergic rhinitis: a double blind randomized crossover trial using the environmental exposure unit","volume":"10","author":"North","year":"2014","journal-title":"Allergy Asthma Clin Immunol"},{"issue":"5 suppl 1","key":"10.1016\/j.anai.2016.07.018_bib20","first-page":"A119","article-title":"Clinical validation of controlled birch pollen challenge in the environmental exposure unit [abstract]","volume":"115","author":"Soliman","year":"2015","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.anai.2016.07.018_bib21","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/S0091-6749(98)70172-1","article-title":"Cetirizine, loratadine, or placebo in subjects with seasonal allergic rhinitis: effects after controlled ragweed pollen challenge in an environmental exposure unit","volume":"101","author":"Day","year":"1998","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2016.07.018_bib22","first-page":"59","article-title":"Randomized double-blind comparison of cetirizine and fexofenadine after pollen challenge in the Environmental Exposure Unit: duration of effect in subjects with seasonal allergic rhinitis","volume":"25","author":"Day","year":"2004","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.anai.2016.07.018_bib23","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1159\/000216185","article-title":"Evaluation of the hypothalamic-pituitary-adrenal axis function in childhood and adolescence","volume":"16","author":"Chrousos","year":"2009","journal-title":"Neuroimmunomodulation"}],"container-title":["Annals of Allergy, Asthma & Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120616304434?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120616304434?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T13:16:09Z","timestamp":1761052569000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1081120616304434"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["S1081120616304434"],"URL":"https:\/\/doi.org\/10.1016\/j.anai.2016.07.018","relation":{},"ISSN":["1081-1206"],"issn-type":[{"value":"1081-1206","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of the novel nasal steroid S0597 tested in an environmental exposure unit","name":"articletitle","label":"Article Title"},{"value":"Annals of Allergy, Asthma & Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anai.2016.07.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}